Aberdare gp ii llc - paul klingenstein investment history in Enteromedics inc

Filed on 2007-11-20 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001181431-07-070726.txt Sec File: edgar/data/1352036/0001181431-07-070726-index.htm

2007-11-20 Aberdare Gp Ii Llc (CIK 1418078) through Paul Klingenstein

Invested in Enteromedics Inc sold 19238 shares at $0 remaining shares owned 0

Series C Preferred Stock Enteromedics Inc Etrm underlying security shares 19238 underlying security title Common Stock

f2 paul klingenstein, a director of enteromedics inc., is a managing partner and aberdare gp ii, llc is the general partner of each of aberdare ventures ii, l.p., aberdare ventures ii (bermuda), l.p. and aberdare ii annex fund, l.p.
f1 the convertible preferred stock automatically converted one-to-one into common stock upon completion of the initial public offering.


Filed on 2007-11-20 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001181431-07-070726.txt Sec File: edgar/data/1352036/0001181431-07-070726-index.htm

2007-11-20 Aberdare Gp Ii Llc (CIK 1418078) through Paul Klingenstein

Invested in Enteromedics Inc sold 38853 shares at $0 remaining shares owned 0

Series B Preferred Stock Enteromedics Inc Etrm underlying security shares 38853 underlying security title Common Stock

f2 paul klingenstein, a director of enteromedics inc., is a managing partner and aberdare gp ii, llc is the general partner of each of aberdare ventures ii, l.p., aberdare ventures ii (bermuda), l.p. and aberdare ii annex fund, l.p.
f1 the convertible preferred stock automatically converted one-to-one into common stock upon completion of the initial public offering.


Filed on 2007-11-20 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001181431-07-070726.txt Sec File: edgar/data/1352036/0001181431-07-070726-index.htm

2007-11-20 Aberdare Gp Ii Llc (CIK 1418078) through Paul Klingenstein

Invested in Enteromedics Inc remaining shares owned 1684

Common Stock Warrant Enteromedics Inc Etrm exercise price 0.46 has valueitem expiration due date 2010-12-12 underlying security shares 1684 underlying security title Common Stock

f2 paul klingenstein, a director of enteromedics inc., is a managing partner and aberdare gp ii, llc is the general partner of each of aberdare ventures ii, l.p., aberdare ventures ii (bermuda), l.p. and aberdare ii annex fund, l.p.
f6 immediately exercisable.


Filed on 2007-11-19 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001181431-07-070482.txt Sec File: edgar/data/1352036/0001181431-07-070482-index.htm

2007-11-15 Aberdare Gp Ii Llc (CIK 1418078) through Paul Klingenstein

Invested in Enteromedics Inc remaining shares owned 1684

Common Stock Warrant Enteromedics Inc Etrm exercise price 0.46 has valueitem expiration due date 2010-12-12 underlying security shares 1684 underlying security title Common Stock

f2 paul klingenstein, a director of enteromedics inc., is a managing partner and aberdare gp ii, llc is the general partner of each of aberdare ventures ii, l.p., aberdare ventures ii (bermuda), l.p. and aberdare ii annex fund, l.p.
f6 immediately exercisable.


Filed on 2007-11-19 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001181431-07-070482.txt Sec File: edgar/data/1352036/0001181431-07-070482-index.htm

2007-11-15 Aberdare Gp Ii Llc (CIK 1418078) through Paul Klingenstein

Invested in Enteromedics Inc remaining shares owned 19238

Series C Preferred Stock Enteromedics Inc Etrm underlying security shares 19238 underlying security title Common Stock

f2 paul klingenstein, a director of enteromedics inc., is a managing partner and aberdare gp ii, llc is the general partner of each of aberdare ventures ii, l.p., aberdare ventures ii (bermuda), l.p. and aberdare ii annex fund, l.p.
f1 the convertible preferred stock will automatically convert one-to-one into common stock upon completion of the initial public offering.


Filed on 2007-11-19 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001181431-07-070482.txt Sec File: edgar/data/1352036/0001181431-07-070482-index.htm

2007-11-15 Aberdare Gp Ii Llc (CIK 1418078) through Paul Klingenstein

Invested in Enteromedics Inc remaining shares owned 38853

Series B Preferred Stock Enteromedics Inc Etrm underlying security shares 38853 underlying security title Common Stock

f2 paul klingenstein, a director of enteromedics inc., is a managing partner and aberdare gp ii, llc is the general partner of each of aberdare ventures ii, l.p., aberdare ventures ii (bermuda), l.p. and aberdare ii annex fund, l.p.
f1 the convertible preferred stock will automatically convert one-to-one into common stock upon completion of the initial public offering.


Filed on 2007-11-19 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001181431-07-070482.txt Sec File: edgar/data/1352036/0001181431-07-070482-index.htm

2007-11-15 Aberdare Gp Ii Llc (CIK 1418078) through Paul Klingenstein

Invested in Enteromedics Inc bought 125000 shares at $8.00 remaining shares owned 125000

Common Stock Enteromedics Inc Etrm Transaction code: P Open market or private purchase of securities

f2 paul klingenstein, a director of enteromedics inc., is a managing partner and aberdare gp ii, llc is the general partner of each of aberdare ventures ii, l.p., aberdare ventures ii (bermuda), l.p. and aberdare ii annex fund, l.p.
f5 represents shares held by aberdare ii annex fund, l.p.


Filed on 2007-11-19 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001181431-07-070482.txt Sec File: edgar/data/1352036/0001181431-07-070482-index.htm

2007-11-15 Aberdare Gp Ii Llc (CIK 1418078) through Paul Klingenstein

Invested in Enteromedics Inc bought 122230 shares at $8.00 remaining shares owned 122230

Common Stock Enteromedics Inc Etrm Transaction code: P Open market or private purchase of securities

f2 paul klingenstein, a director of enteromedics inc., is a managing partner and aberdare gp ii, llc is the general partner of each of aberdare ventures ii, l.p., aberdare ventures ii (bermuda), l.p. and aberdare ii annex fund, l.p.
f4 represents shares held by aberdare ventures ii, l.p.


Filed on 2007-11-19 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001181431-07-070482.txt Sec File: edgar/data/1352036/0001181431-07-070482-index.htm

2007-11-15 Aberdare Gp Ii Llc (CIK 1418078) through Paul Klingenstein

Invested in Enteromedics Inc bought 2770 shares at $8.00 remaining shares owned 2770

Common Stock Enteromedics Inc Etrm Transaction code: P Open market or private purchase of securities

f2 paul klingenstein, a director of enteromedics inc., is a managing partner and aberdare gp ii, llc is the general partner of each of aberdare ventures ii, l.p., aberdare ventures ii (bermuda), l.p. and aberdare ii annex fund, l.p.
f3 represents shares held by aberdare ventures ii (bermuda), l.p.


Filed on 2007-11-14 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 3

Accession 0001181431-07-069098.txt Sec File: edgar/data/1352036/0001181431-07-069098-index.htm

2007-11-14 Aberdare Gp Ii Llc (CIK 1418078) through Paul Klingenstein

Invested in Enteromedics Inc remaining shares owned 0

No Securities Are Held Enteromedics Inc Etrm